+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Europe Genetic Testing Market - Growth, Trends, and Forecast (2019 - 2024)

  • ID: 4591366
  • Report
  • Region: Europe
  • 84 pages
  • Mordor Intelligence
UP TO OFF
until Jul 01st 2019
1 of 5

FEATURED COMPANIES

  • 23andMe Inc.
  • Abbott Laboratories
  • Blueprint Genetics Oy
  • Centogene AG
  • Elitech Group
  • Eurofins Scientific
  • MORE
Market Overview

Genetic testing has been growing at an unprecedented rate; a large panel of tests are now available to screen a number of genetic diseases. Treatment is available for a number of rare genetic diseases and the procedure is gaining importance in scenarios, such as carrier testing, newborn screening, predictive and pre-symptomatic testing, etc. Technologies, such as next-generation sequencing, allow one to carry out a large number of genetic tests rapidly and create databases with information about rare genetic diseases. The European countries have undertaken a number of initiatives to increase awareness among people about the benefits of genetic testing.

There are a number of favorable and collaborative policies that are being implemented by the governments to incorporate genetic testing into the healthcare system and to make insurance reimbursements available to citizens. Cancer genetic testing, Alzheimer's disease testing, and cystic fibrosis testing are the most popular screening tests being carried out in Europe. Till date, genetic testing is being done for a majority of 50 identified hereditary cancer syndromes. Out of them, some of the most common ones include hereditary breast cancer and ovarian cancer syndromes, Li-Fraumeni syndrome, Cowden syndrome, Lynch syndrome, Familial adenomatous polyposis, and retinoblastoma, among others. The practice of genetic testing for hereditary cancer syndromes has changed dramatically in the recent years. In developed countries, like Germany, France, etc., the demand for genetic testing to detect cancer risks is driving the growth of the market. The high GDP expenditure on healthcare, per capita expenditure, increase in awareness among the people, and high income of the citizens are the factors that drive the market in European countries.

Scope of the Report

As per the scope of this report, genetic testing is a test performed to identify the presence of a particular gene/s with a particular sequence of the genome. The gene/s can be identified either directly through sequencing or indirectly through various methods.

Key Market Trends

Diagnostic testing is the segment under type of testing that is expected to grow fastest during the forecast period

Predictive and presymptomatic testing dominated the European genetic testing market system, as it is utilized for the detection of gene mutations related to disorders that appear after birth, frequently in later stages of life. Such tests can be of assistance to individuals having a family member with a genetic disorder, though they are free of any features of the disorder while testing.

Diagnostics testing is expected to register a CAGR of 14.29%, as it is used to diagnose or rule out a specific genetic condition. In most cases, genetic testing is used to confirm a diagnosis when a particular condition is suspected based on physical mutations and symptoms. Furthermore, companies, such as Centogene and NIMGenetics, offer a wide range of genetic diagnostic services in Europe, which is further accelerating the growth of the market.

Competitive Landscape

The European genetic testing market is moderately competitive and consists of several major players. In terms of market share, few of the major players currently dominate the market. However, with technological advancements and product innovations, mid-size to smaller companies are increasing their market presence by introducing new products with fewer prices.

As part of this package, any purchases made up to 30th June will receive the following:

1) Free update of the report in 6 months on request 

2) Free Market Estimate sheet excel data sheet
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • 23andMe Inc.
  • Abbott Laboratories
  • Blueprint Genetics Oy
  • Centogene AG
  • Elitech Group
  • Eurofins Scientific
  • MORE
1 Introduction
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study

2 Research Methodology

3 Executive Summary

4 Market Dynamics
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Emphasis on Early Disease Detection and Prevention
4.2.2 Increasing Demand for Personalized Medicine
4.2.3 Increasing Application of Genetic Testing in Oncology
4.3 Market Restraints
4.3.1 High Costs of Genetic Testing
4.3.2 Social and Ethical Implications of Genetic Testing
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5 Market Segmentation
5.1 Type
5.1.1 Carrier Testing
5.1.2 Diagnostic Testing
5.1.3 Newborn Screening
5.1.4 Predictive and Presymptomatic Testing
5.1.5 Prenatal Testing
5.1.6 Nutrigenomic Testing
5.2 Disease
5.2.1 Alzheimer's Disease
5.2.2 Cancer
5.2.3 Cystic Fibrosis
5.2.4 Sickle Cell Anemia
5.2.5 Duchenne Muscular Dystrophy
5.2.6 Thalassemia
5.2.7 Huntington's Disease
5.2.8 Special Disease
5.2.9 Other Diseases
5.3 Technology
5.3.1 Cytogenetic Testing
5.3.2 Biochemical Testing
5.3.3 Molecular Testing
5.4 Geography
5.4.1 Europe
5.4.1.1 Germany
5.4.1.2 United Kingdom
5.4.1.3 France
5.4.1.4 Italy
5.4.1.5 Spain
5.4.1.6 Rest of Europe

6 Competitive Landscape
6.1 Company Profiles
6.1.1 Illumina Inc.
6.1.2 Abbott Laboratories
6.1.3 23andMe Inc.
6.1.4 F. Hoffmann-La Roche Ltd
6.1.5 Qiagen
6.1.6 Blueprint Genetics Oy
6.1.7 Eurofins Scientific
6.1.8 Centogene AG
6.1.9 Thermo Fisher Scientific
6.1.10 Elitech Group

7 Market Opportunities and Future Trends
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Illumina Inc.
  • Abbott Laboratories
  • 23andMe Inc.
  • F. Hoffmann-La Roche Ltd
  • Qiagen
  • Blueprint Genetics Oy
  • Eurofins Scientific
  • Centogene AG
  • Thermo Fisher Scientific
  • Elitech Group
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4591366
Adroll
adroll